Safe Selection of Genetically Manipulated Human Primary Keratinocytes with Very High Growth Potential Using CD24
Open Access
- 1 December 2007
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 15 (12), 2186-2193
- https://doi.org/10.1038/sj.mt.6300292
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer CellsNew England Journal of Medicine, 2007
- Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cellsNature Medicine, 2006
- The Metastasis-Associated Gene CD24 Is Regulated by Ral GTPase and Is a Mediator of Cell Proliferation and Survival in Human CancerCancer Research, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Retroviral Gene Transfer to Human Epidermal Keratinocytes Correlates with Integrin Expression and Is Significantly Enhanced on FibronectinHuman Gene Therapy, 2002
- Cutaneous gene transfer and therapy: the present and the futureThe Journal of Gene Medicine, 2001
- Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epitheliaGene Therapy, 1998
- Location of stem cells of human hair follicles by clonal analysisCell, 1994
- Three clonal types of keratinocyte with different capacities for multiplication.Proceedings of the National Academy of Sciences of the United States of America, 1987
- Permanent Coverage of Large Burn Wounds with Autologous Cultured Human EpitheliumNew England Journal of Medicine, 1984